Oncothermia Journal
Volume 18



Download the full journal


Fiorentini G (2016) Report from ICHS, Pesaro. Oncothermia Journal 18:7-11

“The 34th Annual Conference of the International Clinical Hyperthermia Society (ICHS) was held in Pesaro, Italy on September 22nd 2016. The meeting was very successful with more than 100 attending doctors and Prof. Giammaria Fiorentini was its chairman. The Conference was dedicated to the memory of Dr. Gianfranco Baronzio, a pioneer of hyperthermia, who suddenly deceased this year due to heart attack. …”


Szasz A (2016) Quo vadis oncological Hyperthermia Update 2016. Oncothermia Journal 18:12-41

“To treat or not to treat? To heat or not to heat? To choose or not to choose?

Challenge of targeting in oncology. Which option de we have in refractory cases when the standard protocols fail? What to choose? …”


Brenner J (2016) Combining hyperthermia with other anticancer methods. Oncothermia Journal 18:42-63

“Opening ceremony of “New-Hope” clinic 1997. Textbook for integrative oncology. Hyperthermia is anexcellent non-toxic anti-cancer method that should be a part of the treatment of almost any cancer patient, with or without other treatment methodes. …”


Szasz O (2016) Workshop, local hyperthermia. Oncothermia Journal 18:64-102

“Hyperthermia is a perfect, capable method in oncology. However, we need further development and think about the decisional points. Development of tumor resistance against chemo-therapy. …”


Roussakow SV (2016) The place and role of clinical hyperthermia in oncological thermotherapy: let’s define what we are talking about. Oncothermia Journal 18:103-115

“T (0C), Type of Thermal Therapy, Type of Tumor Damage, Effect to Cells and Tissues (Tumor, Healthy) …”


Roussakow SV (2016) Pharmacoeconomic study of oncothermia (modulated electro-hyperthermia) in the treatment of lung cancer. Oncothermia Journal 18:116-138

“Pre-requisites of the study: - Lung cancer is a fatal disease with one of the least 5-year survivals among all cancers (14-17% in USA and 12-14% in EU). - In Russia (2012), share of lung cancer is 18,7% in men and 3,6% in women, and it is the first reason of cancer mortality in Russia (17,3% of all cancer deaths). - Current treatments show low efficacy and can’t change the trend of high mortality. –-Thus, study of possibilities to improve the prognosis in lung cancer is of outstanding significance in oncology. …”


Minnaar CA, Kotzen JA, Baeyens A (2016) Hyperthermia combined with radiation in cervical cancer. Oncothermia Journal 18:139-150

“South Africa. Limited resources – not enough Linacs, - PET and CT machines were not working for 6 months. Poverty – Transport problems, - Missed appointments, - Lost to follow ups. Patients present at advanced stage of disease. Immunocompromised – Can’t use Cisplatin as a radiosensitiser. … “


Roussakow SV (2016) Comment to C.A. Minnaar’s results. Oncothermia Journal 18:151-153

“The quality of the study design is an important issue. Per my view, the applied full protocol of radiotherapy by high-brachytherapy, with dose 74 Gy and increased cisplatin - in principle, is the best international protocol for cervix carcinoma. In this study, made by Dr. C. Minnaar, Oncothermia shows significantly better local control after evaluating 100 patients (42%). Differences in survival rates approaching the level of confidence is already at 6 months (when the differences are usually minimal), and an advantage in the quality of life is definitely significant (0.7-3% chance of error). The results are quite remarkable, especially considering the factor of proper control. …”


Ahmed A, Shafi S (2016) Pakistan has highest breast cancer rate among Asian countries. Oncothermia Journal 18:154-155

“Pakistan has the highest breast cancer rate among Asian countries. Young women also have been diagnosed with advanced stage of breast cancer. In rural areas, women are also developing breast cancers every year because it is an inherited disease, which transmits from mother to daughter. These views were expressed by Adeel Ahmed, Manager Marketing and Administration at the Oncothermia Clinics, during an awareness programme about breast cancer at the Lyceum school, held on Thursday. The programme was arranged by Sara Shafi, student of A-Level at the Lyceum School. …”


Brockmann WP (2016) Bestmögliche Ergebnisse der Oncothermia (Elektrohyperthermie) bei der Therapie von Karzinomen und Sarkomen in Kombination. Oncothermia Journal 18:156-169

„Teil A. Die Oncothermie in sehr gut verträglichen lokalen, lokoregionären und systemischen Therapiekombinationen Nicht „am Leben vorbei überleben“ zu müssen, sondern Lebensqualität praktisch uneingeschränkt auch während einer erfolgreichen Krebstherapie samt nachfolgender Remission genießen zu können, ist zu einem wesentlichen und immer häufiger erreichbaren Ziel der Elektrohyperthermie bzw. Oncothermie geworden. …”


Clifford LK Pang (2016) The Immune Regulating Effect of Hyperthermia in Combination with TCM on Cancer Patients. Oncothermia Journal 18:170-179

“In recent years, as the development of integrative cancer treatments, hyperthermia and Traditional Chinese Medicine (TCM) have become significant methods of treating cancer, and the immune regulating effects of them have attracted more and more attentions. In this text, depending on the clinical research data of Clifford Hospital from 2009 to 2013, research progress of hyperthermia in the world, and research achievements of TCM, we discussed the immune regulating effect of hyperthermia in combination with TCM on cancer patients, and its potentiality in anticancer treatments. …”


Shalan N (2016) Oncothermia: New Method of Tumor Therapy. Oncothermia Journal 18:180-190

“Oncothermia is a kind of hyperthermia in oncology. Its efficacy is successfully proven for different advanced cancer localizations, frequently when other therapies fail. Clinical studies and results show its advantages in oncology. Oncothermia is a self-selective process to concentrate the energy on malignant cells targeting their cellular membrane, using the temperature gradient to generate heat-flow between the extra- and intracellular electrolytes, acting to ignite apoptotic processes from outer signal-pathways. Synergies of oncothermia with some chemotherapy were observed, having more efficacy than in the conventional heating combinations. Experiments and clinical results showed the higher benefit of the oncothermia when compare with the results of classical hyperthermia activity at same level of temperature. This paper will review the literature and illustrates the difference between oncothermia and hyperthermia treatment. It will also highlight the effectiveness of oncothermia treatment for different types of tumor. Oncothermia is widely used in numerous clinics and hospitals enjoying definite clinical benefit on elongation of the survival time accompanied with good quality of life. …”


Zahoor S, Mohsin U (2016) Case reports from Oncothermia Clinic. Early experiences. Oncothermia Journal 18:191-193

“Patient 1. 78 y old female, Pakistani

Background - Patient felt a lump on her right breast 7 year ago. It was firm to hard measuring around 6x5cm and there was no significant change in size for next 4 years. Patient did not visit any hospital, after 4 years lump started increasing in size along with some pain in that region. Patient was not willing for any treatment but around 6 months back when patient had severe pain in region she had biopsy done showing invasive ductal carcinoma, ER (+), PR (+). Surgery was done in January 2016, (MRM). Her breast was inflammatory with open wound, fig. 5. The patient refused chemotherapy after surgery, after 2 months patient noticed another lump in her left breast along with bloody discharge from the site around aerola (L) there was fungating wound 7x9cm with irregular margin. Bloody discharge was from right sided scar mark, too. She was generally weak, she had severe pain in hip joint that unable to walk without support. Her active complaints are nausea, heart burn and vomiting. …”


 

Oncotherm